Chemogenomics 5168909 219473148 2008-06-15T11:53:51Z Steinbeck 10120 '''Chemogenomics''' can be defined as the study of [[genomics|genomic]] responses to [[chemical compound]]s. The goal is the rapid identification of novel [[drug]]s and [[drug target]]s embracing multiple early phase [[drug development|drug discovery]] technologies ranging from [[drug target identification|target identification]] and [[drug target validation|validation]], over compound design and [[chemical synthesis]] to biological testing and [[ADME]] profiling. ==See also== *[[Genomics]] **[[Structural genomics]] ** [[Pharmacogenetics]] **[[Pharmacogenomics]] ** [[Toxicogenomics]] * [[Bioinformatics]] * [[Cheminformatics]] ** [[Computational chemistry]] ** [[Molecular modelling]] ** [[QSAR]] * [[Proteochemometrics]] ==References== * ''Chemogenomics in Drug Discovery: A Medicinal Chemistry Perspective'', H. Kubinyi (Editor), G. Müller (Editor), R. Mannhold (Series Editor), G. Folkers (Series Editor), Wiley-VCH, '''2004'''.ISBN 3-527-30987-X ==External links== *[http://www.kubinyi.de/dd-03.pdf Kubinyi's slides] {{Medicinal chemistry}} {{genomics-footer}} {{pharma-stub}} [[Category:Computational chemistry]] [[Category:Genomics]] [[Category:Omics]] [[Category:Pharmacology]] [[Category:Pharmaceutical industry]] [[Category:Cheminformatics]] [[fr:Chimiogénomique]] [[ko:화학유전체학]]